These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7743684)

  • 1. Effects of flecainide on exercise hemodynamics and electrocardiography in patients without structural heart disease.
    Wang JA; Lau CP; Tai YT; Wu BZ
    Clin Cardiol; 1995 Mar; 18(3):140-4. PubMed ID: 7743684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade.
    Ranger S; Talajic M; Lemery R; Roy D; Nattel S
    Circulation; 1989 May; 79(5):1000-6. PubMed ID: 2540920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and Propafenone).
    Vallurupalli S; Pothineni NV; Deshmukh A; Paydak H
    Am J Cardiol; 2015 Sep; 116(5):730-2. PubMed ID: 26100588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function.
    Santinelli V; Arnese M; Oppo I; Matarazzi C; Maione S; Palma M; Giunta A
    Chest; 1993 Apr; 103(4):1068-73. PubMed ID: 8131440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease.
    Sarubbi B; Ducceschi V; Briglia N; Mayer MS; Santangelo L; Iacono A
    Int J Cardiol; 1998 Sep; 66(2):157-64. PubMed ID: 9829329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    Stramba-Badiale M; Lazzarotti M; Facchini M; Schwartz PJ
    Am Heart J; 1994 Nov; 128(5):973-82. PubMed ID: 7524295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of antiarrhythmic drugs on the rate-dependency of QT interval: a study with amiodarone and flecainide.
    Malfatto G; Zaza A; Facchini M
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):535-40. PubMed ID: 18030063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological and hemodynamic effects of vernakalant and flecainide during cardiac resynchronization in dyssynchronous canine hearts.
    van Middendorp LB; Strik M; Houthuizen P; Kuiper M; Maessen JG; Auricchio A; Prinzen FW
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):25-32. PubMed ID: 24084224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effects of flecainide in the swine heart failing from incessant supraventricular tachycardia.
    Trippel DL; Harold ME; Spinale FG; Buckles DS; Gillette PC
    Am Heart J; 1991 Jun; 121(6 Pt 1):1721-6. PubMed ID: 1903580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
    Inama G; Furlanello F; Braito G; Guarnerio M; Vergara G
    G Ital Cardiol; 1991 Feb; 21(2):131-8. PubMed ID: 1907937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Pharmacokinetic and Electrocardiographic Effects of Intratracheal and Intravenous Administration of Flecainide in Anesthetized Pigs.
    Stocco FG; Evaristo E; Silva AC; de Antonio VZ; Pfeiffer J; Rangachari N; Belardinelli L; Verrier RL
    J Cardiovasc Pharmacol; 2018 Sep; 72(3):129-135. PubMed ID: 29923887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model.
    Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L
    Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
    Henthorn RW; Waldo AL; Anderson JL; Gilbert EM; Alpert BL; Bhandari AK; Hawkinson RW; Pritchett EL
    Circulation; 1991 Jan; 83(1):119-25. PubMed ID: 1898640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
    Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
    G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.